SAGE BIONETWORKS: Form 990, tax year 2019

View the entire original 990 at ProPublica ↗

Organization
SAGE BIONETWORKS (EIN 26-4489946)
Tax period
2019-01-01 to 2019-12-31
Filed
2020-11-13
IRS object ID
202003249349301210
Schema version
2019v5.0
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2020-11-13T13:44:55-07:00ReturnTs
Tax Period End2019-12-31TaxPeriodEndDt
Return Type990ReturnTypeCd
Tax Period Begin2019-01-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN264489946EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1SAGE BIONETWORKSBusinessNameLine1Txt
FieldValueIRS element (for citing)
Business Name ControlSAGEBusinessNameControlTxt
Phone2069288250PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line12901 Third Ave Ste 330AddressLine1Txt
CitySeattleCityNm
State AbbreviationWAStateAbbreviationCd
ZIP98121ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonLara MangravitePersonNm
Person TitlePresidentPersonTitleTxt
Phone2069288250PhoneNum
Signature2020-11-13SignatureDt

Filing Security Information FilingSecurityInformation

IP Address IPAddress

FieldValueIRS element (for citing)
I Pv4 Address71.225.165.195IPv4AddressTxt
FieldValueIRS element (for citing)
Tax2019TaxYr
Build TS2021-01-29 14:40:06ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Principal OfficerLara MangravitePrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line12901 Third AveAddressLine1Txt
Address Line2Ste 330AddressLine2Txt
CitySeattleCityNm
State AbbreviationWAStateAbbreviationCd
ZIP98121ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$15,519,146GrossReceiptsAmt
Group Return For Affiliates0GroupReturnForAffiliatesInd
Organization501c3Yes (X)Organization501c3Ind
Website Addresswww.sagebionetworks.orgWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation2009FormationYr
Legal Domicile StateWALegalDomicileStateCd
Activity Or MissionSage Bionetworks is a strategic research organization with a mission to coordinate and link academic and commercial biomedical researchers, patients and citizens through a Commons that represents a new paradigm for genomics intellectual property, researcher cooperation and contributor evolved resources. This mission has several interdependent themes, including: conducting research on network models of disease; building the computational platform for the Commons; and activating public engagement.ActivityOrMissionDesc
Voting Members Governing Body6VotingMembersGoverningBodyCnt
Voting Members Independent5VotingMembersIndependentCnt
Total Employee96TotalEmployeeCnt
Total Volunteers5TotalVolunteersCnt
Total Gross UBI$0TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm$0NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$15,555,426PYContributionsGrantsAmt
CY Contributions Grants$12,402,223CYContributionsGrantsAmt
PY Program Service Revenue$2,402,775PYProgramServiceRevenueAmt
CY Program Service Revenue$3,116,572CYProgramServiceRevenueAmt
PY Investment Income$614PYInvestmentIncomeAmt
CY Investment Income$351CYInvestmentIncomeAmt
PY Other Revenue$0PYOtherRevenueAmt
CY Other Revenue$0CYOtherRevenueAmt
PY Total Revenue$17,958,815PYTotalRevenueAmt
CY Total Revenue$15,519,146CYTotalRevenueAmt
PY Grants And Similar Paid$1,886,803PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$1,377,471CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$8,601,831PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$10,723,543CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$0PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$0CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$35,200CYTotalFundraisingExpenseAmt
PY Other Expenses$4,233,682PYOtherExpensesAmt
CY Other Expenses$4,739,337CYOtherExpensesAmt
PY Total Expenses$14,722,316PYTotalExpensesAmt
CY Total Expenses$16,840,351CYTotalExpensesAmt
PY Revenues Less Expenses$3,236,499PYRevenuesLessExpensesAmt
CY Revenues Less Expenses-$1,321,205CYRevenuesLessExpensesAmt
Total Assets BOY$5,921,898TotalAssetsBOYAmt
Total Assets EOY$4,610,169TotalAssetsEOYAmt
Total Liabilities BOY$1,245,555TotalLiabilitiesBOYAmt
Total Liabilities EOY$2,534,319TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$4,676,343NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$2,075,850NetAssetsOrFundBalancesEOYAmt
MissionSage Bionetworks is a strategic research organization with a mission to coordinate and link academic and commercial biomedical researchers, patients and citizens through a Commons that represents a new paradigm for genomics intellectual property, researcher cooperation and contributor evolved resources. This mission has several interdependent themes, including: conducting research on network models of disease; building the computational platform for the Commons; and activating public engagement. Sage Bionetworks is a non-profit research organization that seeks to develop predictors of disease and accelerate health research through the creation of open systems, incentives, and standards. We create strategies and platforms that empower researchers to share and interpret data on a colossal scale, crowdsource tests for new hypotheses, and contribute to knowledge through community challenges.MissionDesc
Significant New Program Srvc0SignificantNewProgramSrvcInd
Significant Change0SignificantChangeInd
Expense$10,739,954ExpenseAmt
Grant$9,494,996GrantAmt
Revenue$11,298,526RevenueAmt
DescResearch Communities and Challenges: Sage Bionetworks conducts research independently as well as with collaborators worldwide across a variety of disease areas. We work to redefine how complex biological data is gathered, shared and used through open systems, incentives, and norms. Our work includes the building of platforms and services and undertaking research developing predictors relating to health. Research: As biological research has become more data intensive, the breadth of data and expertise required to address research problems has expanded. It requires the integrated efforts of a distributed set of researchers (such as bench/data scientists, data engineers, project managers, administrators, governance experts, and clinical researchers) with shared interests and complementary resources. Effective collaboration depends on a collective ability to work together in trusted ways that lead to translatable biomedical insights. We call this scientific coordination. Sage's scientific coordination stack includes: 1) hypothesis and data generation, 2) data curation, 3) analysis, 4) interpretation, and 5) dissemination. We focus on building a federated network of individuals who bring diverse expertise and approaches to develop robust solutions. New research projects initiated in 2019 included: TREAT-AD - Funded by the NIA to build a diverse portfolio of new therapeutic and diagnostic targets for Alzheimer's disease (AD). Ongoing research communities included: Agora - Funded by the NIA, Agora is a platform that enables researchers to access information about how genes are associated with Alzheimer's disease. It aggregates lines of biological evidence from multiple sources, so researchers can better prioritize which genes they want to follow up on for development of new therapies. All of Us - A program to engage over one million participants in a study to improve the ability to prevent and treat disease based on individual differences in lifestyle, environment and genetics. CD2H (National Center for Data to Health) - With aims to foster collaboration across more than 50 premier medical research institutions within the prestigious Clinical and Translational Science Awards, or CTSA, network. Cancer Systems Biology Consortium (CSBC) - Sage serves as the Coordinating Center for the CSBC and Physical Sciences in Oncology Network (PS-ON) program. This five-year award builds on the work of the NCI funded Sage Bionetworks' Center for Cancer Systems Biology from 2010 through 2015. Human Tumor Atlas Network (HTAN) - Funded by NCI, Sage is the data coordinating center for HTAN which aims to leverage the power of human genome sequencing and other state-of-the-art profiling technologies, to analyze changes in individual tumors. iAtlas -Together with the Institute for Systems Biology, Sage was funded by the Cancer Research Institute to build iAtlas, an online database and web resource designed to help basic and clinical researchers navigate immunological data across multiple tumor types. KiAAP - Funded by Bill and Melinda Gates Foundation, Sage was engaged to support the distributed efforts of BMGF funded data scientists across a number of ongoing research projects in neurocognitive development. MODEL-AD Consortium - Sage runs the Knowledge Portal, the distribution site for data, analysis results, analytical methodology and research tools generated by the AMP-AD and M2OVE-AD Consortia. NF Open Science Initiative (NF-OSI) - A first-of-its-kind Neurofibromatosis research collaboration dedicated to defeating the rare genetic disorder neurofibromatosis type 2. Tumor Neoantigen Selection Alliance (TESLA) - A global research alliance with 30 public and private groups to advance the development of more effective personalized cancer treatments. Funded by the Parker Institute for Cancer. VEOIBD Portal - Funded by the Helmsley Charitable Trust, the VEOIBD Portal aggregates Consortium-identified genotypic data with data from other data sources to find causes and treatments for Inflammatory Bowel Disease (IBD). Challenges: With algorithms playing an increasing role in biomedical analysis and patient care, there's a need for a more rigorous framework for evaluating and improving the capabilities of these algorithms. Sage Bionetworks has pioneered the development of concepts and infrastructure to objectively evaluate algorithms across a broad spectrum of biomedical domains, including bioinformatics, biomedical informatics, and clinical trials. As a trusted partner in hosting challenges and benchmarking initiatives, Sage serves as a broker between data generators and data modelers. We combine technology with biomedical and data science expertise to facilitate the objective assessment of algorithms on critical data sets, including proprietary data and algorithms that cannot be broadly shared. Sage works with the DREAM community to host open challenges. DREAM is recognized as a leader in biomedical competitions, successfully motivating research teams to address fundamental questions about systems biology and translational medicine and to advance computational methods. DREAM challenges invite participants to propose solutions - fostering collaboration and building communities in the process. Sage Bionetworks provides institutional support, along with the infrastructure to host challenges via our Synapse platform. Active Challenges hosted on the Synapse platform in 2019 included: Allen Institute Cell Lineage Reconstruction DREAM Challenge - In this partnership between The Allen Institute and DREAM, this Challenge comprises 3 sub-challenges focused on reconstructing cell lineage trees of different sizes and nature. The goal of this challenge is to mobilize a larger community for evaluating new optimal tree-building methods. BMS Anti-PD Challenge - This challenge consists of a competition-based computational research study that will generate exploratory biomarker data from the data. The Challenge will be administered in three serial stages focused on (1) tumor RNA-Seq, (2) tumor DNA-Seq, and (3) integrated analysis across multiple marker types. EHR DREAM Challenge - This challenge seeks to prospectively predict patient health outcomes in order to 1) lower the barriers to piloting innovative machine learning and data science methods in healthcare, 2) establish clinically relevant prediction benchmarks and evaluation metrics, and 3) minimize the distance between model developers and the clinic to reduce the time for model implementation. IDG Drug-Kinase Binding Challenge - This challenge seeks to evaluate the power of statistical and machine learning models as a systematic and cost-effective means for catalyzing compound-target interaction mapping efforts. Malaria DREAM Challenge - This challenge focuses on the infectious disease agent, malaria, with the goal of predicting the changing biology of Art-resistant malaria. Parkinson's Disease Digital Biomarker DREAM Challenge - This challenge is designed to benchmark methods for the collection and processing of sensor data for development of digital signatures reflective of PD burden and treatment efficacy. A major goal of this research is to use predictive modeling approaches to develop digital predictors of PD based on sensor data. Single Cell Signaling in Breast Cancer - This challenge uses genomic, transcriptomic, and proteomic measurements to evaluate signaling responses of 67 well-characterized breast cell lines to drug treatment at the single-cell level to better understand single-cell signaling and signaling modeling. Tumor Deconvolution DREAM Challenge - The goal of this Challenge is to evaluate the ability of computational methods to deconvolve bulk expression data, reflecting a mixture of cell types, into individual immune components.Desc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

FieldValueIRS element (for citing)
Expense$5,167,892ExpenseAmt
Grant$4,156,138GrantAmt
Revenue$5,333,010RevenueAmt
DescDigital Health:Smartphones and other wearable sensors have put touchscreens and high-fidelity sensors into the pockets of billions of people. These technologies provide an opportunity to paint a rich understanding of health and disease in the everyday world outside of the clinic. They also provide communication tools that allow participants a more active voice in research programs. With our Digital Health program, we work to advance health research through practices that support the design, development and implementation of studies that use technology to monitor health outside of the clinical setting, and the analysis and sharing of the resulting study data. We help to derive and test digital biomarkers. We evaluate analytical methodologies to benchmark best practices in study design and data analysis. Sage's Digital Health program is built around Bridge, a technology platform for conducting biomedical research studies primarily using the ResearchKit (iOS) and ResearchStack (Android) frameworks. Bridge is composed of HIPAA-compliant web services and multi-language SDKs that facilitate: registration and informed consent to participate in research; web-based tools to design and schedule study surveys and sensor-based tasks; acquisition and secure transfer of multiple data types (surveys, sensors, audio, video, or custom data types); a study management portal with daily dashboard updates; and de-identification and storage of study data in our collaborative data science environment, Synapse. Digital Health studies active in 2019 included: Cardiovascular Fitness Module - As part of the PMI All of Us study, Sage is developing methods to use the sensors built into smartphones to assess Cardiorespiratory fitness in a way that can scale to potentially one million participants and become a generally useful tool for clinical research. Mobile Toolbox - Together with Northwestern University and Penn State University, Sage is developing a suite of mobile cognitive tests that will be distributed via Sage's technology platforms for integration into research studies where participants can test themselves using their own smartphone. Mole Mapper MoleMapper is a personalized tool to help users map, measure, and monitor mole using a smartphone camera. mPower Public Researcher Portal - The mPower Public Researcher Portal provides an updated version of the mPower iPhone study piloting new approaches to monitoring key indicators of Parkinson Disease. My BP - The "My BP Lab" research study uses surveys and sensor data collected from participants' phones to quantify and understand their daily stress. The research app, developed by Sage Bionetworks together with UCSF and Samsung, uses sensor data from Samsung mobile phones. Psorcast - This app-based research study collects and validates longitudinal measurements of psoriasis digital biomarkers to establish personalized 'psoriasis forecasts'. The models will be matched to patients based on their measurements, demographics, medical history, genetics, lifestyle, and environmental variables to potentially forecast disease progression, therapeutic efficacy and timing, and dynamics of flare/remission cycles.Desc
FieldValueIRS element (for citing)
Total Other Prog Srvc Expense$0TotalOtherProgSrvcExpenseAmt
Total Other Prog Srvc Grant$0TotalOtherProgSrvcGrantAmt
Total Other Prog Srvc Revenue$0TotalOtherProgSrvcRevenueAmt
Total Program Service Expenses$15,907,846TotalProgramServiceExpensesAmt
Described In Section501c3Yes (1)DescribedInSection501c3Ind
Schedule B RequiredYes (1)ScheduleBRequiredInd
Political Campaign Acty0PoliticalCampaignActyInd
Lobbying Activities0LobbyingActivitiesInd
Subject To Proxy Tax0SubjectToProxyTaxInd
Donor Advised Fund0DonorAdvisedFundInd
Conservation Easements0ConservationEasementsInd
Collections Of Art0CollectionsOfArtInd
Credit Counseling0CreditCounselingInd
Donor Rstr Or Quasi Endowments0DonorRstrOrQuasiEndowmentsInd
Report Land Building EquipmentYes (1)ReportLandBuildingEquipmentInd
Report Investments Other Sec0ReportInvestmentsOtherSecInd
Report Program Related Invst0ReportProgramRelatedInvstInd
Report Other AssetsYes (1)ReportOtherAssetsInd
Report Other LiabilitiesYes (1)ReportOtherLiabilitiesInd
Include FIN48 Footnote0IncludeFIN48FootnoteInd
Independent Audit Fincl Stmt0IndependentAuditFinclStmtInd
Consolidated Audit Fincl Stmt0ConsolidatedAuditFinclStmtInd
School Operating0SchoolOperatingInd
Foreign Office0ForeignOfficeInd
Foreign ActivitiesYes (1)ForeignActivitiesInd
More Than5000 K To OrgYes (1)MoreThan5000KToOrgInd
More Than5000 K To Individuals0MoreThan5000KToIndividualsInd
Professional Fundraising0ProfessionalFundraisingInd
Fundraising Activities0FundraisingActivitiesInd
Gaming Activities0GamingActivitiesInd
Operate Hospital0OperateHospitalInd
Grants To OrganizationsYes (1)GrantsToOrganizationsInd
Grants To Individuals0GrantsToIndividualsInd
Schedule J RequiredYes (1)ScheduleJRequiredInd
Tax Exempt Bonds0TaxExemptBondsInd
Engaged In Excess Benefit Trans0EngagedInExcessBenefitTransInd
PY Excess Benefit Trans0PYExcessBenefitTransInd
Loan Outstanding0LoanOutstandingInd
Grant To Related Person0GrantToRelatedPersonInd
Business Rln With Org Mem0BusinessRlnWithOrgMemInd
Business Rln With Fam Mem0BusinessRlnWithFamMemInd
Business Rln With35 Ctrl Ent0BusinessRlnWith35CtrlEntInd
Deductible Non Cash ContriYes (1)DeductibleNonCashContriInd
Deductible Art Contribution0DeductibleArtContributionInd
Terminate Operations0TerminateOperationsInd
Partial Liquidation0PartialLiquidationInd
Disregarded Entity0DisregardedEntityInd
Related Entity0RelatedEntityInd
Related Organization Ctrl Ent0RelatedOrganizationCtrlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org0TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp0ActivitiesConductedPrtshpInd
Schedule O RequiredYes (1)ScheduleORequiredInd
IRP Document14IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Employee96EmployeeCnt
Employment Tax Returns FiledYes (1)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over Limit0UnrelatedBusIncmOverLimitInd
Foreign Financial Account0ForeignFinancialAccountInd
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTransInd
Taxable Party Notification0TaxablePartyNotificationInd
Nondeductible Contributions0NondeductibleContributionsInd
Quid Pro Quo Contributions0QuidProQuoContributionsInd
Form8282 Property Disposed Of0Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct0RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct0PayPremiumsPrsnlBnftCntrctInd
Indoor Tanning Services0IndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht Pymt0SubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst Inc0SubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members6GoverningBodyVotingMembersCnt
Independent Voting Member5IndependentVotingMemberCnt
Family Or Business Rln0FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties0DelegationOfMgmtDutiesInd
Change To Org Documents0ChangeToOrgDocumentsInd
Material Diversion Or Misuse0MaterialDiversionOrMisuseInd
Members Or Stockholders0MembersOrStockholdersInd
Election Of Board Members0ElectionOfBoardMembersInd
Decisions Subject To Approva0DecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (1)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (1)MinutesOfCommitteesInd
Officer Mailing Address0OfficerMailingAddressInd
Local Chapters0LocalChaptersInd
Form990 Provided To Gvrn BodyYes (1)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (1)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (1)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (1)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (1)WhistleblowerPolicyInd
Document Retention Policy0DocumentRetentionPolicyInd
Compensation Process CEOYes (1)CompensationProcessCEOInd
Compensation Process Other0CompensationProcessOtherInd
Investment In Joint Venture0InvestmentInJointVentureInd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

FieldValueIRS element (for citing)
PersonDiane GaryPersonNm
Phone2069288243PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line12901 Third Ave Ste 330AddressLine1Txt
CitySeattleCityNm
State AbbreviationWAStateAbbreviationCd
ZIP98121ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (27 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtAverage Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRtOfficerOfficerIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtKey EmployeeKeyEmployeeIndHighest Compensated EmployeeHighestCompensatedEmployeeIndIndividual Trustee Or DirectorIndividualTrusteeOrDirectorInd
Lara Mangravite
President500Yes (X)$256,228$0$36,230
John Wilbanks
Chief Commons Officer500$237,336$0$35,065Yes (X)
Mike Kellen
Chief Technology Officer500$216,576$0$23,937Yes (X)
Justin Guinney
Vice President, Computational Oncology500$202,067$0$34,853Yes (X)
Larsson Omberg
Vice President, Systems Biology500$180,545$0$30,468Yes (X)
Bruce Hoff
Director, Synapse Team500$172,187$0$36,835Yes (X)
Diane Gary
Secretary500Yes (X)$174,943$0$30,064
Erin Mounts
Principle SW Engineer500$168,635$0$29,486Yes (X)
Ljubomir Bradic
Director, Design500$160,617$0$28,220Yes (X)
Dwayne Jeng
Principal SW Engineer500$160,781$0$19,818Yes (X)
Alx Dark
Principle Software Engineer500$161,520$0$11,918Yes (X)
Patricia Arean
Director10$2,000$0$0Yes (X)
Kathy Hudson
Director10$2,000$0$0Yes (X)
Anna Barker
Director10$2,000$0$0Yes (X)
Laura Germine
Director10$2,000$0$0Yes (X)
Lawrence Hunter
Director10$2,000$0$0Yes (X)
Jeffrey Kaye
Director10$2,000$0$0Yes (X)
Amanda Tan
Director10$2,000$0$0Yes (X)
Jennifer Wagner
Director10$2,000$0$0Yes (X)
Cecilia Arradaza
Director10$2,000$0$0Yes (X)
Stephen Friend
Chairman of the Board10$0$0$0Yes (X)
Eric Schadt
Director/Chair of Scientific Advisory Board10$0$0$0Yes (X)
Tony Ford-Hutchinson
Director10$0$0$0Yes (X)
Gustavo Stolovitsky
Director10$0$0$0Yes (X)
Tetsu Maruyama
Director10$0$0$0Yes (X)
Paul Boutros
Director10$0$0$0Yes (X)
Joon-Ho Yu
Director10$0$0$0Yes (X)
FieldValueIRS element (for citing)
Total Reportable Comp From Org$2,109,435TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$0TotReportableCompRltdOrgAmt
Total Other Compensation$316,894TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K44IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed0FormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (1)TotalCompGreaterThan150KInd
Compensation From Other Srcs0CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (2 entries)

Address Line1ContractorAddress/USAddress/AddressLine1TxtCityContractorAddress/USAddress/CityNmState AbbreviationContractorAddress/USAddress/StateAbbreviationCdZIPContractorAddress/USAddress/ZIPCdServicesServicesDescCompensationCompensationAmt
Stockard Simon
44564 SE 144th StNorth BendWA98045IT Design$152,910
Chou Communications
5431 45th Ave WSeattleWA98199Communications and outreach services$157,111
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K2CntrctRcvdGreaterThan100KCnt
Federated Campaigns$0FederatedCampaignsAmt
Membership Dues$0MembershipDuesAmt
Fundraising$0FundraisingAmt
Related Organizations$0RelatedOrganizationsAmt
Government Grants$11,108,215GovernmentGrantsAmt
All Other Contributions$1,294,008AllOtherContributionsAmt
Noncash Contributions$250,304NoncashContributionsAmt
Total Contributions$12,402,223TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp

FieldValueIRS element (for citing)
DescScientific CollaborationsDesc
Business541711BusinessCd
Total Revenue Column$3,116,572TotalRevenueColumnAmt
Related Or Exempt Func Income$3,116,572RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$0ExclusionAmt

Total Oth Program Service Rev TotalOthProgramServiceRevGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
Related Or Exempt Func Income$0RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$0ExclusionAmt
FieldValueIRS element (for citing)
Total Program Service Revenue$3,116,572TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$351TotalRevenueColumnAmt
Related Or Exempt Func Income$351RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$0ExclusionAmt

Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
Related Or Exempt Func Income$0RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$0ExclusionAmt

Royalties Revenue RoyaltiesRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
Related Or Exempt Func Income$0RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$0ExclusionAmt

Rental Income Or Loss RentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Real$0RealAmt
Personal$0PersonalAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Securities$0SecuritiesAmt
Other$0OtherAmt
FieldValueIRS element (for citing)
Contri Rpt Fundraising Event$0ContriRptFundraisingEventAmt
Other Revenue Total$0OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$15,519,146TotalRevenueColumnAmt
Related Or Exempt Func Income$3,116,923RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue$0UnrelatedBusinessRevenueAmt
Exclusion$0ExclusionAmt
FieldValueIRS element (for citing)
Info In Schedule O Part IXYes (X)InfoInScheduleOPartIXInd

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$1,082,939TotalAmt
Program Services$1,082,939ProgramServicesAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt

Foreign Grants ForeignGrantsGrp

FieldValueIRS element (for citing)
Total$294,532TotalAmt
Program Services$294,532ProgramServicesAmt

Benefits To Members BenefitsToMembersGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$1,529,037TotalAmt
Program Services$1,274,454ProgramServicesAmt
Management And General$243,864ManagementAndGeneralAmt
Fundraising$10,719FundraisingAmt

Comp Disqual Persons CompDisqualPersonsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$7,349,781TotalAmt
Program Services$6,931,133ProgramServicesAmt
Management And General$403,083ManagementAndGeneralAmt
Fundraising$15,565FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$490,697TotalAmt
Program Services$459,205ProgramServicesAmt
Management And General$30,787ManagementAndGeneralAmt
Fundraising$705FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$802,216TotalAmt
Program Services$779,168ProgramServicesAmt
Management And General$22,415ManagementAndGeneralAmt
Fundraising$633FundraisingAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$551,812TotalAmt
Program Services$497,306ProgramServicesAmt
Management And General$52,599ManagementAndGeneralAmt
Fundraising$1,907FundraisingAmt

Fees For Services Management FeesForServicesManagementGrp

FieldValueIRS element (for citing)
Total$7,803TotalAmt
Program Services$7,236ProgramServicesAmt
Management And General$546ManagementAndGeneralAmt
Fundraising$21FundraisingAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$107,303TotalAmt
Program Services$99,497ProgramServicesAmt
Management And General$7,511ManagementAndGeneralAmt
Fundraising$295FundraisingAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$90,441TotalAmt
Program Services$83,863ProgramServicesAmt
Management And General$6,330ManagementAndGeneralAmt
Fundraising$248FundraisingAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Fees For Services Prof Fundraising FeesForServicesProfFundraising

FieldValueIRS element (for citing)
Total$0TotalAmt
Fundraising$0FundraisingAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$2,954,571TotalAmt
Program Services$2,923,926ProgramServicesAmt
Management And General$29,488ManagementAndGeneralAmt
Fundraising$1,157FundraisingAmt

Advertising AdvertisingGrp

FieldValueIRS element (for citing)
Total$1,747TotalAmt
Program Services$1,620ProgramServicesAmt
Management And General$122ManagementAndGeneralAmt
Fundraising$5FundraisingAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$72,103TotalAmt
Program Services$66,858ProgramServicesAmt
Management And General$5,047ManagementAndGeneralAmt
Fundraising$198FundraisingAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$155,443TotalAmt
Program Services$146,936ProgramServicesAmt
Management And General$8,186ManagementAndGeneralAmt
Fundraising$321FundraisingAmt

Royalties RoyaltiesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$741,296TotalAmt
Program Services$687,374ProgramServicesAmt
Management And General$51,887ManagementAndGeneralAmt
Fundraising$2,035FundraisingAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$363,861TotalAmt
Program Services$338,193ProgramServicesAmt
Management And General$24,699ManagementAndGeneralAmt
Fundraising$969FundraisingAmt

Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$103,366TotalAmt
Program Services$97,487ProgramServicesAmt
Management And General$5,657ManagementAndGeneralAmt
Fundraising$222FundraisingAmt

Interest InterestGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Payments To Affiliates PaymentsToAffiliatesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt
Program Services$0ProgramServicesAmt
Management And General$0ManagementAndGeneralAmt
Fundraising$0FundraisingAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$26,430TotalAmt
Program Services$24,507ProgramServicesAmt
Management And General$1,850ManagementAndGeneralAmt
Fundraising$73FundraisingAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$27,908TotalAmt
Program Services$25,878ProgramServicesAmt
Management And General$1,953ManagementAndGeneralAmt
Fundraising$77FundraisingAmt

All Other Expenses AllOtherExpensesGrp

FieldValueIRS element (for citing)
Total$87,065TotalAmt
Program Services$85,734ProgramServicesAmt
Management And General$1,281ManagementAndGeneralAmt
Fundraising$50FundraisingAmt

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$16,840,351TotalAmt
Program Services$15,907,846ProgramServicesAmt
Management And General$897,305ManagementAndGeneralAmt
Fundraising$35,200FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$564,479BOYAmt
EOY$207,271EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

FieldValueIRS element (for citing)
BOY$3,134,674BOYAmt
EOY$1,359,383EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$1,021,718BOYAmt
EOY$1,599,688EOYAmt

Receivables From Officers Etc ReceivablesFromOfficersEtcGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Inventories For Sale Or Use InventoriesForSaleOrUseGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$88,014BOYAmt
EOY$84,954EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$96,150LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$31,285LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$91,295BOYAmt
EOY$64,865EOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
BOY$1,021,718BOYAmt
EOY$1,294,008EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$5,921,898BOYAmt
EOY$4,610,169EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$750,306BOYAmt
EOY$839,264EOYAmt

Grants Payable GrantsPayableGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Deferred Revenue DeferredRevenueGrp

FieldValueIRS element (for citing)
BOY$457,667BOYAmt
EOY$1,590,661EOYAmt

Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Escrow Account Liability EscrowAccountLiabilityGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Loans From Officers Directors LoansFromOfficersDirectorsGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Other Liabilities OtherLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$37,582BOYAmt
EOY$104,394EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$1,245,555BOYAmt
EOY$2,534,319EOYAmt
FieldValueIRS element (for citing)
Organization Follows FASB117Yes (X)OrganizationFollowsFASB117Ind

No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$2,352,896BOYAmt
EOY$781,842EOYAmt

Donor Restriction Net Assets DonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$2,323,447BOYAmt
EOY$1,294,008EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$4,676,343BOYAmt
EOY$2,075,850EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$5,921,898BOYAmt
EOY$4,610,169EOYAmt
FieldValueIRS element (for citing)
Info In Schedule O Part XIYes (X)InfoInScheduleOPartXIInd
Reconcilation Revenue Expnss-$1,321,205ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst$0NetUnrlzdGainsLossesInvstAmt
Donated Services And Use Fclts$0DonatedServicesAndUseFcltsAmt
Investment Expense$0InvestmentExpenseAmt
Prior Period Adjustments$0PriorPeriodAdjustmentsAmt
Other Changes In Net Assets-$1,279,288OtherChangesInNetAssetsAmt
Info In Schedule O Part XIIYes (X)InfoInScheduleOPartXIIInd
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or Review0AccountantCompileOrReviewInd
FS Audited0FSAuditedInd
Federal Grant Audit RequiredYes (1)FederalGrantAuditRequiredInd
Federal Grant Audit PerformedYes (1)FederalGrantAuditPerformedInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Public Organization170Yes (X)PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$6,230,203CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$5,050,380CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$7,337,399CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$12,490,269CurrentTaxYearMinus1YearAmt
Current Tax Year$13,586,784CurrentTaxYearAmt
Total$44,695,035TotalAmt

Tax Rev Levied Orgnztnl Bnft170 TaxRevLeviedOrgnztnlBnft170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$0CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$0CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$0CurrentTaxYearMinus2YearsAmt
Total$0TotalAmt

Govt Furn Srvc Fclts Vl170 GovtFurnSrvcFcltsVl170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$0CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$0CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$0CurrentTaxYearMinus2YearsAmt
Total$0TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$6,230,203CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$5,050,380CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$7,337,399CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$12,490,269CurrentTaxYearMinus1YearAmt
Current Tax Year$13,586,784CurrentTaxYearAmt
Total$44,695,035TotalAmt
FieldValueIRS element (for citing)
Public Support Total170$44,695,035PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$1,056CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$380CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$258CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$614CurrentTaxYearMinus1YearAmt
Current Tax Year$351CurrentTaxYearAmt
Total$2,659TotalAmt

Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$0CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$0CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$0CurrentTaxYearMinus2YearsAmt
Total$0TotalAmt

Other Income170 OtherIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$1,464,542CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$2,230,377CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$3,001,123CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$2,402,778CurrentTaxYearMinus1YearAmt
Current Tax Year$3,116,572CurrentTaxYearAmt
Total$12,215,392TotalAmt
FieldValueIRS element (for citing)
Total Support$56,913,086TotalSupportAmt
Gross Receipts Rltd Activities$0GrossReceiptsRltdActivitiesAmt
Public Support CY1700.78532PublicSupportCY170Pct
Public Support PY1700.78505PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170Yes (X)ThirtyThrPctSuprtTestsCY170Ind

Form990 Schedule A Part VI Form990ScheduleAPartVIGrp

FieldValueIRS element (for citing)
Form And Line ReferenceSchedule A, Part II, Line 10FormAndLineReferenceDesc
ExplanationFee for service revenue for research collaborations.ExplanationTxt

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

FieldValueIRS element (for citing)
ContributorRESTRICTEDContributorNum

Contributor Business Name ContributorBusinessName

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor US Address ContributorUSAddress

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Total ContributionsRESTRICTEDTotalContributionsAmt

Schedule D IRS990ScheduleD

Land LandGrp

FieldValueIRS element (for citing)
Investment Cost Or Other Basis$0InvestmentCostOrOtherBasisAmt
Other Cost Or Other Basis$0OtherCostOrOtherBasisAmt
Book Value$0BookValueAmt

Buildings BuildingsGrp

FieldValueIRS element (for citing)
Investment Cost Or Other Basis$0InvestmentCostOrOtherBasisAmt
Other Cost Or Other Basis$0OtherCostOrOtherBasisAmt
Depreciation$0DepreciationAmt
Book Value$0BookValueAmt

Leasehold Improvements LeaseholdImprovementsGrp

FieldValueIRS element (for citing)
Investment Cost Or Other Basis$0InvestmentCostOrOtherBasisAmt
Other Cost Or Other Basis$0OtherCostOrOtherBasisAmt
Depreciation$0DepreciationAmt
Book Value$0BookValueAmt

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Investment Cost Or Other Basis$96,150InvestmentCostOrOtherBasisAmt
Other Cost Or Other Basis$0OtherCostOrOtherBasisAmt
Depreciation$31,285DepreciationAmt
Book Value$64,865BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

FieldValueIRS element (for citing)
Investment Cost Or Other Basis$0InvestmentCostOrOtherBasisAmt
Other Cost Or Other Basis$0OtherCostOrOtherBasisAmt
Depreciation$0DepreciationAmt
Book Value$0BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$64,865TotalBookValueLandBuildingsAmt

Other Assets Org OtherAssetsOrgGrp

FieldValueIRS element (for citing)
DescPledges Receivable, net of current portionDesc
Book Value$1,294,008BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Other Assets$1,294,008TotalBookValueOtherAssetsAmt
Federal Income Tax Liability$0FederalIncomeTaxLiabilityAmt

Other Liabilities Org OtherLiabilitiesOrgGrp

FieldValueIRS element (for citing)
DescDeferred rentDesc
Amt$104,394Amt
FieldValueIRS element (for citing)
Total Liability$104,394TotalLiabilityAmt

Schedule F IRS990ScheduleF

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Account Activities Outside US AccountActivitiesOutsideUSGrp (2 entries)

RegionRegionTxtOfficesOfficesCntEmployeeEmployeeCntType Of Activities ConductedTypeOfActivitiesConductedTxtSpecific Services ProvidedSpecificServicesProvidedTxtRegion Total ExpendituresRegionTotalExpendituresAmt
Europe (including Iceland and Greenland)00GrantmakingData generation for our Coordinated$240,876
North America (including Canada and Mexico, but not the United States)00GrantmakingMcGill and Agora$55,656
FieldValueIRS element (for citing)
Total Office0TotalOfficeCnt
Total Employee0TotalEmployeeCnt
Total Spent$296,532TotalSpentAmt

Grants To Org Outside US GrantsToOrgOutsideUSGrp (2 entries)

RegionRegionTxtPurpose Of GrantPurposeOfGrantTxtCash GrantCashGrantAmtManner Of Cash DisbursementMannerOfCashDisbursementTxtNon Cash AssistanceNonCashAssistanceAmt
Europe (including Iceland and Greenland)To enable testing of the therapeutic hypothesis, and to further prioritize targets for more extensive drug development programs, we will develop a toolkit of experimental reagents and data - termed a Target Enabling Package (TEP) - for 10 AMP-AD targets. The TEP is meant to bridge the gap between identification of candidate targets, and the ability to launch a chemical biology or drug discovery program. A TEP will typically include purified protein, biochemical assays, crystal structures, and tool compounds. Other components may be provided where relevant. In some cases, the TEP will identify sequences for mutation in CRISPR/Cas9 loss-of-function editing, but in most cases it will enable the initiation of a small molecule chemical probe or antibody discovery project by proving that the target is tractable and reducing the barrier to drug discovery. All TEP components will be openly distributed as described in the resource sharing plan.$240,876Wire Transfer$0
North America (including Canada and Mexico, but not the United States)Validation of antibody reagents for 15 high priority AMP-AD Targets$55,656Check$0
FieldValueIRS element (for citing)
Total501c3 Org0Total501c3OrgCnt
Total Other Org2TotalOtherOrgCnt
Transfer To Foreign Corp0TransferToForeignCorpInd
Interest In Foreign Trust0InterestInForeignTrustInd
Foreign Corp Ownership0ForeignCorpOwnershipInd
Passive Foreign Investmest Co0PassiveForeignInvestmestCoInd
Foreign Partnership0ForeignPartnershipInd
Boycott Countries0BoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceSchedule F, Part I, Line 2FormAndLineReferenceDesc
ExplanationMonitoring the use of grant funds: In some cases, grants received by Sage Bionetworks are passed on to sub-recipients through a sub-award agreement. The Grant Manager is responsible for initiating the sub-award agreement after obtaining budget approval from the PI and Operations Director. In issuing a sub-award, the Grant Manager is responsible for: obtaining verification of the sub-awardee's facilities and administrative rates and Single Audit Reports; reviewing the prime award special terms and conditions to determine whether they are applicable to the sub-award; and determining whether the sub-awardee meets all of the other administrative and regulatory requirements of the prime award. Once the sub-award has been issued, the Grant Manager is responsible for forwarding the fully executed sub-award documents to the Accounting Manager to ensure proper billing. Payments are made only after the sub-award agreement has been fully executed by both parties.ExplanationTxt

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Grant Records MaintainedYes (1)GrantRecordsMaintainedInd

Recipient Table RecipientTable (6 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdRecipient EINRecipientEINCash GrantCashGrantAmtNon Cash AssistanceNonCashAssistanceAmtPurpose Of GrantPurposeOfGrantTxtAddress Line2USAddress/AddressLine2Txt
Institute for Systems Biology
401 Terry Ave NSeattleWA98109912003593$511,388$0Assist in the development of an integrative platform: the Pan-cancer Immune Atlas (iAtlas) to host the data and results derived from the PanCancerAtlas Immune Response Working Group and to provide external investigators with the ability to reproduce results of the IRWG. Provide expertise related to the analyses of the metabolic and transcriptional regulatory network sand will work collaboratively to develop, implement, test, and benchmark all methods related to the dynamic analyses of the transcriptional regulatory and metabolic networks aimed at drug target discovery for Alzheimer's Disease. The Institute for Systems Biology will provide expertise related to the (dynamic) analyses of the metabolic and transcriptional regulatory networks and will work collaboratively to develop, implement, test, and benchmark all methods related to the dynamic analyses of the transcriptional regulatory and metabolic networks aimed at drug target discovery for the AMP-AD CC project.
Icahn School of Medicine at Mount Sinai
1 Gustave L Levy PlaceNew YorkNY11029136171197$286,189$0Perform computational and integrative analysis of the AMP/AD data sets to develop a set of high probability therapeutic targets necessary for their assessment and integration into drug discovery efforts for the Agora project.
University of California San Diego
9500 Gilman DrLa JollaCA92093956006144$66,103$0To determine the test validity and test-retest reliability of smartphone-based measurement of CRF. To evaluate the feasibility and acceptability of using a smartphone application to measure CRF. This will be examined using a system usability scale and assessing compliance and overall satisfaction with the administered protocol. Provide expert consultation in the use of agile science methods for creating strategies for facilitating sustained engagement with the MPower 2.0 application. This includes providing expertise related to behavioral theory, human centered design, and measurement strategies. Develop an experimental design and broader strategy for gathering evidence to foster iterative improvement on mPower to foster improved sustained engagement with the tool.
Stanford University
450 Serra MallStanfordCA94305941156365$18,834$0Oversee the genomic profiling, analysis, and computational modeling of metastatic colorectal cancer patient data. Prioritize candidate metastasis associated genes and provide for modeling in organoids. Contribute to the analysis of cell fitness and clone size distributions in the metastatic colon organoid models. Interpret the data from the microenvironmental arrays.
University of Arizona
220 W 6th StTucsonAZ85701742652689$141,708$0The goal of the project is to develop small molecules (from in silico docking on the CD44 binding pocket and peptidomimetics of CD44 peptide) and peptides (from the peptide array) to disrupt the interaction between CD44 and FERM domain-containing proteins. These tools will help to define if the proteins are druggable, and whether targeting protein-protein interactions can have a more specific effects than global inhibition of the ectodomain of CD44 using antibodies or small molecules. This will pave the way to testing therapeutic hypotheses for AMP-AD targets relating to protein-protein interactions.
University of North Carolina at Chapel Hill
910 Raleigh RdChapel HillNC27514566001393$58,717$0Collaboration on the CRI iAtlas project by defining regression models and validation methods for use in implementing statistical learning models for biomarker development in iAtlas. Add comprehensive tumor antigen prediction from multiple genomic sources to iAtlas datasets. Harmonize and curate data from additional IO clinical trials with genomic data for analysis using the IO response module.3916
FieldValueIRS element (for citing)
Total501c3 Org6Total501c3OrgCnt
Total Other Org6TotalOtherOrgCnt

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceSchedule I, Part I, Line 2FormAndLineReferenceDesc
ExplanationIn 2019, Sage Bionetworks issued grants and contributions. Contributions were given in support of an awarded institution's project. Monitoring the use of grant funds: In some cases, grants received by Sage Bionetworks are passed on to sub-recipients through a sub-award agreement. The Grant Manager is responsible for initiating the sub-award after obtaining budget approval from the PI and the Head of Operations. In issuing a sub-award, the Grant Manager is responsible for: obtaining verification of the sub-awardee's facilities and administrative rates and Single Audit Reports; reviewing the prime award special terms and conditions to determine whether they are applicable to the sub-award; and determining whether the sub-awardee meets all of the other administrative and regulatory requirements of the prime award. Once the sub-award has been issued, the Grant Manager is responsible for monitoring sub-award activity, including compliance with all reporting requirements. The Grant Manager is also responsible for forwarding the fully executed sub-award documents to the Accounting Manager to ensure proper billing. Payments are made only after the sub-award agreement has been fully executed by both parties.ExplanationTxt

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
First Class Or Charter TravelYes (X)FirstClassOrCharterTravelInd
Written Policy Ref T And E ExpnssYes (1)WrittenPolicyRefTAndEExpnssInd
Substantiation RequiredYes (1)SubstantiationRequiredInd
Compensation CommitteeYes (X)CompensationCommitteeInd
Severance Payment0SeverancePaymentInd
Supplemental Nonqual Rtr Plan0SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm0EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng Org0CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs0CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng Org0CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs0CompBsdNetEarnsRltdOrgsInd
Any Non Fixed Payments0AnyNonFixedPaymentsInd
Initial Contract Exception0InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (11 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
Lara Mangravite
President$256,228$0$0$0$0$0$0$0$36,230$0$292,458$0$0$0
Diane Gary
Secretary$174,943$0$0$0$0$0$0$0$30,064$0$205,007$0$0$0
John Wilbanks
Chief Commons Officer$237,336$0$0$0$0$0$0$0$35,065$0$272,401$0$0$0
Mike Kellen
Chief Technology Officer$216,576$0$0$0$0$0$0$0$23,937$0$240,513$0$0$0
Justin Guinney
Vice President, Computational Oncology$202,067$0$0$0$0$0$0$0$34,853$0$236,920$0$0$0
Larsson Omberg
Vice President, Systems Biology$180,545$0$0$0$0$0$0$0$30,468$0$211,013$0$0$0
Bruce Hoff
Director, Synapse Team$172,187$0$0$0$0$0$0$0$36,835$0$209,022$0$0$0
Erin Mounts
Principle SW Engineer$168,635$0$0$0$0$0$0$0$29,486$0$198,121$0$0$0
Dwayne Jeng
Principal SW Engineer$160,781$0$0$0$0$0$0$0$19,818$0$180,599$0$0$0
Alx Dark
Principle Software Engineer$161,520$0$0$0$0$0$0$0$11,918$0$173,438$0$0$0
Ljubomir Bradic
Director, Design$160,617$0$0$0$0$0$0$0$28,220$0$188,837$0$0$0

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
Schedule J, Part I, Line 1aAll travel conducted per the company travel policy.
Schedule J, Part I, Line 3Setting executive compensation is the responsibility of the Board of Directors Compensation Committee.

Schedule M IRS990ScheduleM

FieldValueIRS element (for citing)
Form8283 Received0Form8283ReceivedCnt
Any Property That Must Be Held0AnyPropertyThatMustBeHeldInd
Review Process Unusual NC Gifts0ReviewProcessUnusualNCGiftsInd
Third Parties Used0ThirdPartiesUsedInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferenceSchedule M, Part I, Line 33FormAndLineReferenceDesc
ExplanationReceived In-Kind legal servicesExplanationTxt

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (7 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
Form 990, Part VI, Section B, Line 11bThe 990 is reviewed by the company's Vice President of Operations and President prior to filing.
Form 990, Part VI, Section B, Line 12cSage Bionetworks has a Financial Conflict of Interest Policy (FCOI) that complies with the National Institutes of Health-specific requirements promoting objectivity in research, 42 CFR Part 50 subpart F. On an annual basis, Sage Bionetworks Officers, Directors, and members of committees of Board of Directors authorized to act on behalf of the board, and employees designated by the President of Sage Bionetworks, including any employees serving as an investigator on a federal/Public Health Services award, must review and update the Sage Bionetworks Annual Conflict of Interest Questionnaire. New employees serving as investigators are required to complete a FOCI form within 30 days of their start date. In addition, all investigators must submit an ad hoc disclosure of a Significant Financial Interest they acquire or discover during the course of they year within 30 days of discovering or acquiring the Significant Financial Interest. Forms are reviewed and any potential conflicts are referred to the President and outside counsel.
Form 990, Part VI, Section B, Line 15Executive compensation was set by the Board of Directors Compensation Committee.
Form 990, Part VI, Section C, Line 19The organization's financials are contained within its 990 returns. These returns are available to the public through organizations such as Guidestar, dedicated to publicizing information about nonprofit organizations. The organization's governing documents and conflict of interest policies are available upon request.
Form 990, Part IX, Line 11gScientific Research Expenses $1,080,421; Assembly Expenses $150,847; Platform/Scientific Computing Expenses $1,328,243;Professional Services Expenses $395,060
Form 990, Part XI, Line 9Revenue released from restrictions and In-kind legal revenue
Form 990, Part XII, Line 3bDue to the Covid pandemic, our Single Audit was delayed and was underway but not finalized at the time our 990 return was due. If the audit results in a change of our financial information, Sage Bionetworks will immediately file an amendment.

Reasonable Cause Explanation ReasonableCauseExplanation

FieldValueIRS element (for citing)
ExplanationFiling is within the extension deadline and has been held up due to the Covid pandemic affecting our operations.ExplanationTxt

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.